Koo, I'll gladly eat lots of crow if Covid succeeds and my money is in for the humble pie party.      :)

I do do agree with Chicagoest - Covid success is the last chance for Don before Hepa takes over. But I better be a bit careful. This wiley old devil may come up with a new trick to get funding for Covid and BoM2 and to pay out the Hepa debenture.

On your trial cost numbers in the Feb 2021 update Don stated the 2.5 year trial cost for BoM2 would be $60 to $70 million USA dollars and this was in comparison to the 5 year trial proposed by a BP for a 5 year 10,000 patient trial at a cost of $200,000,000 USD. Of course we have no proof that there actually was a BP proposal or if this was just more of Don's fiction to illustrate how efficient he is.

So I'm curious, has Don magically found a way to cut the BoM2 cost to $30-$40 million? Are these his new numbers?

GLTA

Toinv